Eddit

Version vom 28. Mai 2020, 17:15 Uhr

• Further reading

• Unproven ideas

32311318 ä. SARS-CoV-2 and viral sepsis: observations and hypotheses
32325026 2020. Endothelial cell infection and endotheliitis in COVID-19

• Reviews on covid19 disease

• Clinical guidelines and advice

32360205 ä. What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?
32336069 2020. What should a cardiologist know about coronavirus disease 2019?
32272080 2020. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
32203709 ä. Treatment for severe acute respiratory distress syndrome from COVID-19

• Structure of covid19

32350227 2020. Characteristics of SARS-CoV-2 isolated from asymptomatic carrier in Tokyo
32007145 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
32342926 2020. Properties of Coronavirus and SARS-CoV-2

• Target binding and uptake
• Cytopathic effects

• Secretion and shedding

32304647 2020. SARS-CoV-2 shedding and infectivity
32304646 ä. SARS-CoV-2 shedding and infectivity ? Authors reply

• Innate sensing

• Immunology

32213336 ä. SARS-CoV-2: virus dynamics and host response
32213337 ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
32344307 2020. COVID-19 type III hypersensitivity reaction
32344314 2020. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents

• Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome

32353251 ä. COVID-19 cytokine storm: the interplay between inflammation and coagulation

• Early symptoms

• Systemic disease, any manifestations

• Co-Infection

32307254 ä. Invasive fungal diseases during COVID-19: We should be prepared
32297939 ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise
32293646 ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens

• ARDS

• Pulmonary embolism, coagulation

32330428 ä. Hospital-based use of thromboprophylaxis in patients with COVID-19

• Hematology

• Microvascular

• Heart

32334650 ä. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes
32360126 2020. Myocardial injury and COVID-19: Possible mechanisms

• Neurology, ophthalmology, orl

32320008 ä. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection
32275288 ä. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
32232433 2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China
32304632 ä. Utility of hyposmia and hypogeusia for the diagnosis of COVID-19
32304629 ä. Smell and taste dysfunction in patients with COVID-19
32246917 2020. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence?
32361098 2020. Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?
32344276 ä. COVID-19 and Anosmia in Tehran, Iran

• Dermatology

• Gastroenterology, hepatology

32336473 ä. COVID-19 y aparato digestivo
32240876 2020. Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms

• Kidney, urology

• Pathobiology

32199493 ä. Viral dynamics in mild and severe cases of COVID-19
32330440 ä. Mediastinal lymphadenopathy in patients with severe COVID-19
32105638 ä. Viral load of SARS-CoV-2 in clinical samples
32085846 ä. Pathological findings of COVID-19 associated with acute respiratory distress syndrome
32341791 2020. Thoughts on COVID-19 and autoimmune diseases
32344305 ä. A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: potential implications for the SARS-CoV-2 modus operandi

• Disease Models

• Similar diseases and pathomechanisms

32370951 ä. Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic

• Diagnosis (Laboratory)

32224308 ä. Understanding COVID-19: what does viral RNA load really mean?
32342928 2020. Upper respiratory tract sampling in COVID-19
32342927 2020. Diagnostic performance of COVID-19 serology assays
32217609 2020. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS?CoV-2/COVID-19
32361529 ä. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19

• Diagnosis (Lung CT, Sonography)

32222163 ä. CT screening for early diagnosis of SARS-CoV-2 infection ? Authors reply
32222164 ä. CT screening for early diagnosis of SARS-CoV-2 infection
32105637 ä. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
32105641 2020. COVID-19 pneumonia: what has CT taught us?
32220663 ä. The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions
32275856 2020. POCUS in COVID-19: pearls and pitfalls
32321656 ä. La radiologia en el diagnostico de la neumonia por SARS-CoV-2 (COVID-19)
32355892 ä. Radiological findings for diagnosis of SARS-CoV-2 pneumonia (COVID-19)?
32344309 ä. COVIDiagnosis-Net: Deep Bayes-SqueezeNet based Diagnostic of the Coronavirus Disease 2019 (COVID-19) from X-Ray Images

• Diagnosis (other modalities)

32344326 2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries

• Respiration mgmt

32340627 2020. Recommendations from the CSO-HNS taskforce on performance of tracheotomy during the COVID-19 pandemic
32278367 ä. COVID-19: Respiratory support outside the intensive care unit
32325017 ä. Use of non-invasive ventilation for patients with COVID-19: a cause for concern?
32325016 ä. High versus low PEEP in non-recruitable collapsed lung tissue: possible implications for patients with COVID-19
32178774 2020. COVID-19, ECMO, and lymphopenia: a word of caution
32145829 2020. Respiratory support for patients with COVID-19 infection

• Risk and special populations

32224304 2020. COVID-19 infection in children
32142639 ä. Guidelines for pregnant women with suspected SARS-CoV-2 infection
32171067 2020. Sex difference and smoking predisposition in patients with COVID-19
32171062 2020. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
32332856 ä. COVID-19 in persons with haematological cancers
32353398 ä. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China
32344304 ä. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?
32339776 2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease

• The morbid survivor

32219356 ä. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
32369030 2020. Considerations for Postacute Rehabilitation for Survivors of COVID-19
32333842 2020. The key role of palliative care in response to the COVID-19 tsunami of suffering
32197096 ä. COVID-19 in pregnant women ? Authors reply

• Case reports

32224310 ä. Clinical and virological data of the first cases of COVID-19 in Europe: a case series
32164830 2020. COVID-19 with spontaneous pneumomediastinum

• Case series

32220650 ä. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study
32087116 2020. Asymptomatic cases in a family cluster with SARS-CoV-2 infection
32105632 ä. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

• Registries

32305438 ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19
32309814 ä. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

• Trials

32290293 2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials
32363333 ä. A real-time dashboard of clinical trials for COVID-19

• Candidate Compounds Covid19

32325035 ä. Plea for multitargeted interventions for severe COVID-19
32311322 ä. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
32311324 ä. Hydroxychloroquine prophylaxis for COVID-19 contacts in India
32113510 2020. Convalescent plasma as a potential therapy for COVID-19
32113509 2020. COVID-19: combining antiviral and anti-inflammatory treatments
32304640 ä. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
32368738 2020. Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology
32368737 2020. Preventing COVID-19-induced pneumonia with anticytokine therapy
32372026 ä. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
32119961 2020. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
32222463 ä. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
32251634 2020. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
32217117 2020. COVID-19: Melatonin as a potential adjuvant treatment
32360622 2020. Comment on Melatonin as a potential adjuvant treatment for COVID-19

32334009 2020. Correspondence COVID-19: Melatonin as a potential adjuvant treatment
32278693 2020. In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
32340389 2020. Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
32359771 ä. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
32198163 2020. Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
32265331 2020. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection
32328576 2020. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?
32296777 2020. Mesenchymal stem cells and management of COVID-19 pneumonia
32289117 2020. Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus
32292906 2020. The role of afferent pulmonary innervation in ARDS associated with COVID-19 and potential use of resiniferatoxin to improve prognosis: A review
C7147214 ä. Potential TRPV1 blockade to treat severe lung dysfunction in COVID-19 infection
32352081 ä. Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19
32352080 ä. Does vitamin D status impact mortality from SARS-CoV-2 infection?
32313880 ä. PAK1-blockers: Potential Therapeutics against COVID-19?
32292909 2020. Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies
32220710 2020. Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2
32361169 2020. Why not consider an endothelin receptor antagonist against SARS?CoV?2?

• riociguat?

32361100 2020. Amantadine as a drug to mitigate the effects of COVID-19
32353740 2020. Serum albumin-mediated strategy for the effective targeting of SARS-CoV-2
32353742 ä. Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19?
32353743 2020. Purposing Saikosaponins for the treatment of COVID-19
32344275 2020. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)
32344303 ä. Oxytocin as a potential defence against Covid-19?
32361588 2020. Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19
32361099 2020. The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19
32344315 2020. N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome
32353741 2020. Phytotherapeutics and SARS-CoV-2 infection: Potential role of bioflavonoids
32344313 ä. Can pioglitazone be potentially useful therapeutically in treating patients with covid-19?
32344312 2020. Potential effect of natural and anabolizan steroids in elderly patient with COVID-19
32344310 2020. Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality
32344308 2020. Suggesting Ritonavir against COVID-19/SARS-CoV-2
32339778 ä. Dapsone and Doxycycline could be potential treatment modalities for COVID-19
32339777 2020. May IL-17 have a role in COVID-19 infection?
32335456 2020. The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases?

• Remission, recurrence and persistence

32303482 ä. Re-emergence of SARS-CoV2 in a discharged COVID-19 case
32299784 ä. How do we decide to de-isolate COVID-19 patients?
32105304 2020. Positive RT-PCR Test Results in Patients Recovered From COVID-19

• Other routes of infection

32276848 ä. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019
32224116 ä. Do children need a longer time to shed SARS-CoV-2 in stool than adults?
32035510 2020. 2019-nCoV transmission through the ocular surface must not be ignored
32199469 2020. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

• Biophysics of aerosols

32340347 2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough
32360356 ä. Putting some context to the aerosolization debate around SARS-CoV-2

• Passive protective equipment

32129805 2020. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
32203710 2020. Rational use of face masks in the COVID-19 pandemic
32344688 2020. 3-D Printed Protective Equipment during COVID-19 Pandemic

• Running your hospital

32304634 2020. The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19
32325021 ä. COVID-19: impact on cancer workforce and delivery of care
32359409 ä. An Italian programme for COVID-19 infection in multiple sclerosis
32302533 ä. Taking care of older patients with cancer in the context of COVID-19 pandemic
32251622 2020. Preparing African anticancer centres in the COVID-19 outbreak
32220659 ä. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection
32213339 2020. Cancer care in the time of COVID-19
32066541 2020. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
32240603 2020. COVID-19: global consequences for oncology
32142622 2020. Risk of COVID-19 for patients with cancer

32142621 2020. Risk of COVID-19 for patients with cancer
32353271 2020. Suicide prevention during the COVID-19 outbreak
32353270 2020. Public health messaging and harm reduction in the time of COVID-19
32353266 2020. Mental health services in Italy during the COVID-19 outbreak
32353264 2020. Key ethical questions for research during the COVID-19 pandemic
32304649 2020. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
32199511 2020. Mental health care for international Chinese students affected by the COVID-19 outbreak
32085843 2020. Mental health services for older adults in China during the COVID-19 outbreak
32085841 ä. Online mental health services in China during the COVID-19 outbreak
32305079 2020. Kidney transplant programmes during the COVID-19 pandemic
32305078 ä. Blood transfusion strategies and ECMO during the COVID-19 pandemic
32304639 ä. Impact of COVID-19 on people with cystic fibrosis
32203711 ä. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases
32278368 ä. Challenges in lung cancer therapy during the COVID-19 pandemic
32061335 2020. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics
32192586 ä. COVID-19: the need for continuous medical education and training
32333858 ä. Screening and triage at health-care facilities in Timor-Leste during the COVID-19 pandemic
32105633 2020. Staff safety during emergency airway management for COVID-19 in Hong Kong
32368736 2020. Global rheumatology in the time of COVID-19
32215896 2020. Die COVID-19-Pandemie und das HNO-Fachgebiet: Worauf kommt es aktuell an?
32251934 2020. Acute leukemia in the time of COVID-19
32318330 2020. Rewriting the rules for care of MDS and AML patients in the time of COVID-19
32358568 ä. Frequently asked questions regarding SARS-CoV-2 in cancer patients?recommendations for clinicians caring for patients with malignant diseases
32284798 2020. How should front-line general practitioners use personal protective equipment (PPE)?
32376774 2020. Impact of COVID-19 pandemic on SLE: beyond the risk of infection
32341913 2020. Being a front-line dentist during the Covid-19 pandemic: a literature review
32312491 ä. Medication Shortages During the COVID-19 Crisis: What We Must Do
32303589 2020. Coping with COVID: How a Research Team Learned To Stay Engaged in This Time of Physical Distancing
C7138174 ä. How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus

• Mental aspects of health professionals

32035030 2020. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus
32085839 2020. Mental health care for medical staff in China during the COVID-19 outbreak

• Socio-psychiatric aspects of the status hygienicus

32330430 ä. Suicide risk and prevention during the COVID-19 pandemic
32353269 2020. COVID-19, unemployment, and suicide
32085840 2020. Psychological interventions for people affected by the COVID-19 epidemic
32275858 ä. COVID-19, school closures, and child poverty: a social crisis in the making
32277874 ä. Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis?
32199471 2020. COVID-19 and the consequences of isolating the elderly
32339480 ä. COVID-19: home poisoning throughout the containment period

• Avoiding clinical medicine in other diseases

32283124 ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic

• Occupational medicine, workplace security and status hygienicus

32305069 ä. Protecting workers aged 60?69 years from COVID-19

• Economic aspects of the status hygienicus

32325710 2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response
32305533 ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review
32292707 ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns
32048740 2020. Economic impacts of Wuhan 2019?nCoV on China and the world
32311326 ä. COVID-19 disrupts vaccine delivery
32341616 ä. Exploration of alternative supply chains and distributed manufacturing in response to COVID-19; a case study of medical face shields

• Educational aspects of the status hygienicus

• Host, vector, one health, atmospheric aspects

31967321 2020. Cross?species transmission of the newly identified coronavirus 2019?nCoV
32346658 ä. SARS-CoV-2 and Bats: From Flight to Fighting COVID-19

• Origin of Covid19

32277970 ä. Strategies to trace back the origin of COVID-19
32007135 2020. Origins of MERS-CoV, and lessons for 2019-nCoV
32060933 2020. 2019_nCoV/SARS?CoV?2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses

• Epidemiology

32087115 ä. Open access epidemiological data from the COVID-19 outbreak
32087114 ä. An interactive web-based dashboard to track COVID-19 in real time
32220651 ä. COVID-19 in children: the link in the transmission chain
32275868 ä. Invisible spread of SARS-CoV-2
32275869 ä. Making decisions to mitigate COVID-19 with limited knowledge
32171390 ä. Real estimates of mortality following COVID-19 infection
32213329 ä. Scientific and ethical basis for social-distancing interventions against COVID-19
32213332 ä. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study
32353347 ä. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study
32330441 ä. The important role of serology for COVID-19 control
32330439 ä. Connecting clusters of COVID-19: an epidemiological and serological investigation
32330438 ä. Targeting COVID-19 interventions towards migrants in humanitarian settings
32246906 ä. Modelling COVID-19 transmission: from data to intervention
32304631 ä. COVID-19 and the coming epidemic in US immigration detention centres
32330458 ä. Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study
32311320 ä. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study
32247329 2020. Why inequality could spread COVID-19
32243775 2020. COVID-19 and immigration detention in the USA: time to act
32220653 ä. The Italian health system and the COVID-19 challenge
32220654 ä. COVID-19: extending or relaxing distancing control measures
32199083 ä. The resilience of the Spanish health system against the COVID-19 pandemic
32339478 ä. COVID-19 deaths in Lombardy, Italy: data in context
32197116 ä. Prisons and custodial settings are part of a comprehensive response to COVID-19
32171054 2020. COVID-19: a potential public health problem for homeless populations
32222165 ä. Efforts escalate to protect homeless people from COVID-19 in UK
32359414 2020. COVID-19 in Nigeria: a disease of hunger
32171063 ä. Adoption of COVID-19 triage strategies for low-income settings
32233563 2020. Effect of delay in diagnosis on transmission of COVID-19
32233562 2020. A mathematical model for the novel coronavirus epidemic in Wuhan, China
32233561 2020. Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak
32327866 2020. Dynamic models for Coronavirus Disease 2019 and data analysis
32307104 ä. The Italian Outbreak of COVID-19: Conditions, Contributors, and Concerns
32361528 2020. Airborne route and bad use of ventilation systems as non-negligible factors in SARS-CoV-2 transmission
32344306 2020. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
32360770 2020. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus
32362714 2020. Incidence of COVID-19 among immigration police: Observation from Thailand

• Failure of politics and public health guidance

32272085 2020. Economic sanctions and Iran s capacity to respond to COVID-19

• Failure of executive measures

• Political abuse of Covid19

• Lost people

• Lost civilization

• History of covid19 exploration

• misc.

32203708 ä. COVID-19 outbreak: less stethoscope, more ultrasound
32192583 2020. COVID-19: delay, mitigate, and communicate
32344311 2020. 2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruc?al?ty of Fur?n and relevance w?th cancer

• Research tools

C7118609 ä. NetNCSP: Nonoverlapping closed sequential pattern mining

• from the ads
• [lifechemicals.com antiviral candidate drugs]
• [biomol.com assays cytokines general spectrum]
• [labospace.com custom single probe assay 400 possible cytokines and so on]
• [codexdna.com dna synthesis]
• [eclipsebio.com around rna]

• Current state of coviki.org